ロード中...
24-Month Phase I/II Clinical Trial of Bimatoprost Sustained-Release Implant (Bimatoprost SR) in Glaucoma Patients
OBJECTIVE: The objective of this study was to evaluate the safety and intraocular pressure (IOP)-lowering effects over 24 months of biodegradable bimatoprost sustained-release implant (Bimatoprost SR) administration versus topical bimatoprost 0.03% in patients with open-angle glaucoma (OAG). METHODS...
保存先:
| 出版年: | Drugs |
|---|---|
| 主要な著者: | , , , , , , , , , |
| フォーマット: | Artigo |
| 言語: | Inglês |
| 出版事項: |
Springer International Publishing
2019
|
| 主題: | |
| オンライン･アクセス: | https://ncbi.nlm.nih.gov/pmc/articles/PMC7007425/ https://ncbi.nlm.nih.gov/pubmed/31884564 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1007/s40265-019-01248-0 |
| タグ: |
タグ追加
タグなし, このレコードへの初めてのタグを付けませんか!
|